Latest Asx News

High-Tech Metals has increased its ownership in the Mt Eureka Gold Project to 75%, consolidating its position in Western Australia’s Northern Goldfields and setting the stage for expanded exploration and resource growth.

Perpetual Credit Income Trust (PCI) has announced a $267 million entitlement offer priced at a 9.1% discount, aiming to bolster its investment capacity. The offer includes a shortfall facility and top-up options for eligible unitholders and wholesale investors.

ANZ Group Holdings Limited has announced its 2025 final dividend of 83 cents per share, accompanied by a continuation of its Dividend Reinvestment and Bonus Option Plans offering a 1.5% discount. Shareholders have until mid-November to participate.

SportsHero Limited has resumed trading on the ASX following a Supreme Court ruling addressing the company’s failure to lodge required cleansing notices for recent share issues.

Terrain Minerals has successfully raised $1.32 million through a share placement to fund exploration at its Smokebush Project, targeting high-grade gold and silver deposits.

Lunnon Metals has secured shareholder approval for its Ore Purchase Agreement and chosen Hampton Mining as the preferred contractor for its Lady Herial gold open pit, moving closer to operational commencement pending regulatory permits.

Invex Therapeutics Ltd has been suspended from trading on the ASX due to a failure to maintain the minimum number of directors required by law. The suspension will remain until the company rectifies its governance structure and complies with listing rules.

Clean TeQ Water has raised A$6 million through a placement supported by major shareholders to fund its expanding international water and resource recovery projects while strengthening its balance sheet.

Gladiator Resources has provided detailed clarifications to the ASX regarding its agreement with Apex USA Resources LLC for rare earth tenements in California, highlighting ongoing disputes and incomplete project milestones.

Epsilon Healthcare has posted its highest-ever quarterly receipts of $2.919 million, reflecting a robust turnaround since exiting voluntary administration in mid-2024. The company’s strategic sale and leaseback deal has also enabled significant debt reduction, setting the stage for sustained growth.

Epsilon Healthcare reports a strong rebound with a 73% revenue increase in the June quarter, driven by contract manufacturing and new pharmacy operations. The company is emerging from restructuring with renewed financial strength and growth prospects.

Epsilon Healthcare has commenced operations of its new pharmacy division and extended a key loan facility, signaling a strategic pivot towards integrated healthcare and financial stability after recent restructuring.